Progressive discontinuation of antihypertensive medications did not lower risk for mortality compared with usual care among ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...

Therapy is often hyped up as the ultimate fix for any mental health concern. So if you’ve ever walked out of a session thinking, Well, why didn’t it do anything for me???, we get your frustration. In ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

Event-free survival (EFS) improved by 60% and overall survival (OS) by 50% with the antibody-drug conjugate (ADC) enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) versus upfront radical ...

Atezolizumab improved DFS and OS in ctDNA-positive MIBC patients, with a median DFS of 9.9 months vs 4.8 months for placebo. Serial ctDNA testing may offer a more accurate assessment of MRD and early ...

Physicians and patient advocacy groups are rallying behind a renewed legislative effort in Congress to amend what they claim ...

Botox is widely known to iron out wrinkles, but it could also help ease phantom limb pain in Ukrainian war amputees, ...

Moment of Clarity has released a new resource, titled “Using TMS Therapy for BPD Recovery,” now available on their website.